Hologic Gets BARDA Contract to Support IVD Approval of COVID Assays
Funding will bring Hologic’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Aptima SARS-CoV-2 assay in line with the FDA’s IVD standards.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Funding will bring Hologic’s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Aptima SARS-CoV-2 assay in line with the FDA’s IVD standards.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Cancer, Sequencing Systems |
Precision for Medicine detailed its NGS initiative which aims to improve the accuracy and speed of identifying cancer mutations in tumors.
Read MorePosted by Andy Lundin | Oct 27, 2022 | Covid 19, Research |
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Chris Wolski | Oct 27, 2022 | Digital Pathology |
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Andy Lundin | Oct 25, 2022 | Infectious Diseases |
Researchers from UVA have been selected to help establish a national pathogen genomics surveillance network.
Read More